Business Wire||January 13, 2017
Decision makes CGM technology available to Medicare patients.
U.S. Food and Drug Administration||December 21, 2016
It is the first to replace fingerstick testing for diabetes treatment decisions.
PR Newswire||December 20, 2016
The Animas Corporation (part of JnJ) OneTouch Vibe Plus Insulin Pump also received the Health Canada License.
Kalorama Information||November 3, 2016
The companies are noted based on recent revenue growth, product development, and distribution deals.
Abbott Laboratories||September 28, 2016
The device requires no fingersticks to calibrate the system.
Business Wire||September 14, 2016
Study brings company closer to providing its Omnipod system to diabetics.
Dexcom Inc.||May 2, 2016
Germany, Switzerland, Austria “attractive markets” for Decom’s CGM tech.
Allied Market Research||January 6, 2016
Report predicts growth rate of 31.3 percent through 2021.
Sign up now to receive the free weekly newsletter, and more!